CDC20 and breast cancer: Interestingly, a converse relationship of Cdc20 and SMAR1 was observed in breast cancer patient samples, with under expression of SMAR1 in higher grades supporting that oncogenic Cdc20 limits SMAR1 levels in higher grade of breast cancer.